881 related articles for article (PubMed ID: 19423196)
1. Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines.
Chhabria MT; Jani MH
Eur J Med Chem; 2009 Oct; 44(10):3837-44. PubMed ID: 19423196
[TBL] [Abstract][Full Text] [Related]
2. Thienopyrimidines as novel inhibitors of Mycobacterium tuberculosis: synthesis and in-vitro studies.
Rashmi P; Nargund LV; Hazra K; Chandra JN
Arch Pharm (Weinheim); 2011 Jul; 344(7):459-65. PubMed ID: 21598298
[TBL] [Abstract][Full Text] [Related]
3. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
Abdel-Rahman HM; El-Koussi NA; Hassan HY
Arch Pharm (Weinheim); 2009 Feb; 342(2):94-9. PubMed ID: 19173243
[TBL] [Abstract][Full Text] [Related]
4. Facile one-pot synthesis and antimycobacterial evaluation of pyrazolo[3,4-d]pyrimidines.
Trivedi A; Dodiya D; Surani J; Jarsania S; Mathukiya H; Ravat N; Shah V
Arch Pharm (Weinheim); 2008 Jul; 341(7):435-9. PubMed ID: 18574851
[TBL] [Abstract][Full Text] [Related]
5. A small library of trisubstituted pyrimidines as antimalarial and antitubercular agents.
Agarwal A; Srivastava K; Puri SK; Sinha S; Chauhan PM
Bioorg Med Chem Lett; 2005 Dec; 15(23):5218-21. PubMed ID: 16171994
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitubercular activity of novel 4-substituted imidazolyl-2,6-dimethyl-N3,N5-bisaryl-1,4-dihydropyridine-3,5-dicarboxamides.
Fassihi A; Azadpour Z; Delbari N; Saghaie L; Memarian HR; Sabet R; Alborzi A; Miri R; Pourabbas B; Mardaneh J; Mousavi P; Moeinifard B; Sadeghi-Aliabadi H
Eur J Med Chem; 2009 Aug; 44(8):3253-8. PubMed ID: 19371979
[TBL] [Abstract][Full Text] [Related]
7. Novel imidazo[2,1-b][1,3,4]thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents.
Alegaon SG; Alagawadi KR; Sonkusare PV; Chaudhary SM; Dadwe DH; Shah AS
Bioorg Med Chem Lett; 2012 Mar; 22(5):1917-21. PubMed ID: 22325950
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitubercular screening of imidazole derivatives.
Pandey J; Tiwari VK; Verma SS; Chaturvedi V; Bhatnagar S; Sinha S; Gaikwad AN; Tripathi RP
Eur J Med Chem; 2009 Aug; 44(8):3350-5. PubMed ID: 19272678
[TBL] [Abstract][Full Text] [Related]
9. Novel dihydropyrimidines as a potential new class of antitubercular agents.
Trivedi AR; Bhuva VR; Dholariya BH; Dodiya DK; Kataria VB; Shah VH
Bioorg Med Chem Lett; 2010 Oct; 20(20):6100-2. PubMed ID: 20813528
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro evaluation of substituted pyrimido[5,4-d]pyrimidines as a novel class of anti-Mycobacterium tuberculosis agents.
Bacelar AH; Carvalho MA; Proença MF
Eur J Med Chem; 2010 Jul; 45(7):3234-9. PubMed ID: 20416983
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel [1,2]-diamines with antituberculosis activity.
Meng Q; Luo H; Chen Y; Wang T; Yao Q
Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of mycobacterial replication by pyrimidines possessing various C-5 functionalities and related 2'-deoxynucleoside analogues using in vitro and in vivo models.
Srivastav NC; Rai D; Tse C; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2010 Aug; 53(16):6180-7. PubMed ID: 20718497
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines.
Nayyar A; Monga V; Malde A; Coutinho E; Jain R
Bioorg Med Chem; 2007 Jan; 15(2):626-40. PubMed ID: 17107805
[TBL] [Abstract][Full Text] [Related]
15. 1,3-Azoles from ortho-naphthoquinones: synthesis of aryl substituted imidazoles and oxazoles and their potent activity against Mycobacterium tuberculosis.
Moura KC; Carneiro PF; Pinto Mdo C; da Silva JA; Malta VR; de Simone CA; Dias GG; Jardim GA; Cantos J; Coelho TS; da Silva PE; da Silva EN
Bioorg Med Chem; 2012 Nov; 20(21):6482-8. PubMed ID: 23000294
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-tubercular activity of a series of 2-sulfonamido/trifluoromethyl-6-substituted imidazo[2,1-b]-1,3,4-thiadiazole derivatives.
Gadad AK; Noolvi MN; Karpoormath RV
Bioorg Med Chem; 2004 Nov; 12(21):5651-9. PubMed ID: 15465343
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antimycobacterial evaluation of various 6-substituted pyrazolo[3,4-d]pyrimidine derivatives.
Trivedi A; Vaghasiya S; Dholariya B; Dodiya D; Shah V
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):893-9. PubMed ID: 21054238
[TBL] [Abstract][Full Text] [Related]
18. Multi-component synthesis of dihydropyrimidines by iodine catalyst at ambient temperature and in-vitro antimycobacterial activity.
Zalavadiya P; Tala S; Akbari J; Joshi H
Arch Pharm (Weinheim); 2009 Aug; 342(8):469-75. PubMed ID: 19565601
[TBL] [Abstract][Full Text] [Related]
19. Functionalized 3-amino-imidazo[1,2-a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors.
Odell LR; Nilsson MT; Gising J; Lagerlund O; Muthas D; Nordqvist A; Karlén A; Larhed M
Bioorg Med Chem Lett; 2009 Aug; 19(16):4790-3. PubMed ID: 19560924
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs.
Braendvang M; Bakken V; Gundersen LL
Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
